Efficacy: Treatment group	Placebo	ABA 10/10	ABA 30/10
Treated	N=100	ABA 10/10 N=99	N=99
Confirmed CR at Month 12, %	3.0	3.0	5.1
CR at Month 12, %	8.0	10.1	10.1
RI at Month 12, %	55.0	52.5	55.6
RR at Month 12, %	33.0	39.4	45.5
Post-hoc: CRrev at Month 12, %	12.0	22.2	15.2